Trade Summary

4 days ago, Hyep Ivan, serving as Chief Financial Officer at Bicara Therapeutics Inc. (BCAX), sold 28,000 shares at $28.85 per share, for a total transaction value of $807,671.96. Following this transaction, Hyep Ivan now holds 129,855 shares of BCAX.

This sale represents a 17.74% decrease in Hyep Ivan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, July 8, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 10, 2026 at 4:10 PM ET, 2 days after the trade was made.

Bicara Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.